Intact Investment Management’s AbbVie ABBV Stock Holding History

Intact Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.4M	Buy	107,630 +19,840	+23%	+$4.4M	0.67%	37
2025 Q4	$20.1M	Sell	87,790 -17,410	-17%	-$3.97M	0.58%	45
2025 Q3	$24.4M	Buy	105,200 +2,500	+2%	+$509K	0.74%	37
2025 Q2	$19.1M	Sell	102,700 -8,200	-7%	-$1.52M	0.65%	42
2025 Q1	$23.2M	Sell	110,900 -300	-0.3%	-$58.3K	0.8%	34
2024 Q4	$19.8M	Sell	111,200 -1,800	-2%	-$331K	0.69%	34
2024 Q3	$22.3M	Buy	113,000 +9,570	+9%	+$1.79M	0.74%	37
2024 Q2	$17.7M	Buy	103,430 +50,430	+95%	+$8.35M	0.66%	34
2024 Q1	$9.65M	Sell	53,000 -19,600	-27%	-$3.38M	0.38%	65
2023 Q4	$11.3M	Sell	72,600 -1,800	-2%	-$262K	0.46%	50
2023 Q3	$11.1M	Buy	74,400 +1,300	+2%	+$191K	0.48%	46
2023 Q2	$9.85M	Buy	73,100 +200	+0.3%	+$29.3K	0.4%	52
2023 Q1	$11.6M	Sell	72,900 -34,500	-32%	-$5.27M	0.48%	49
2022 Q4	$17.4M	Buy	107,400 +14,900	+16%	+$2.28M	0.75%	31
2022 Q3	$12.4M	Sell	92,500 -9,400	-9%	-$1.35M	0.41%	52
2022 Q2	$15.6M	Buy	101,900 +10,400	+11%	+$1.59M	0.49%	46
2022 Q1	$14.8M	Sell	91,500 -20,900	-19%	-$3.04M	0.38%	59
2021 Q4	$15.2M	Sell	112,400 -50,000	-31%	-$5.91M	0.39%	57
2021 Q3	$17.5M	Buy	162,400 +14,400	+10%	+$1.65M	0.49%	44
2021 Q2	$16.7M	Hold	148,000	–	–	0.47%	48
2021 Q1	$16M	Buy	148,000 +48,700	+49%	+$5.21M	0.48%	47
2020 Q4	$10.6M	Buy	99,300 +3,400	+4%	+$327K	0.34%	64
2020 Q3	$8.39M	Buy	95,900 +8,400	+10%	+$791K	0.29%	72
2020 Q2	$8.59M	Buy	87,500 +48,500	+124%	+$4.27M	0.32%	68
2020 Q1	$2.96M	Sell	39,000 -79,200	-67%	-$6.75M	0.13%	122
2019 Q4	$10.5M	Buy	118,200 +7,700	+7%	+$639K	0.36%	61
2019 Q3	$8.37M	Buy	110,500 +46,700	+73%	+$3.2M	0.3%	70
2019 Q2	$4.64M	Buy	63,800 +18,300	+40%	+$1.44M	0.17%	102
2019 Q1	$3.67M	Sell	45,500 -62,600	-58%	-$5.12M	0.13%	123
2018 Q4	$9.96M	Hold	108,100	–	–	0.4%	53
2018 Q3	$10.2M	Hold	108,100	–	–	0.36%	57
2018 Q2	$10M	Hold	108,100	–	–	0.36%	58
2018 Q1	$10.2M	Buy	+108,100	New	+$11.9M	0.4%	50
2016 Q4	–	Sell	-8,400	Closed	-$530K	–	264
2016 Q3	$530K	Sell	8,400 -2,700	-24%	-$175K	0.02%	191
2016 Q2	$687K	Sell	11,100 -3,700	-25%	-$225K	0.03%	177
2016 Q1	$845K	Hold	14,800	–	–	0.03%	155
2015 Q4	$876K	Hold	14,800	–	–	0.04%	149
2015 Q3	$805K	Buy	14,800 +2,700	+22%	+$176K	0.04%	151
2015 Q2	$813K	Sell	12,100 -2,600	-18%	-$170K	0.03%	156
2015 Q1	$860K	Sell	14,700 -1,800	-11%	-$109K	0.03%	155
2014 Q4	$1.08M	Sell	16,500 -3,400	-17%	-$214K	0.04%	140
2014 Q3	$1.15M	Buy	19,900 +3,100	+18%	+$172K	0.05%	127
2014 Q2	$948K	Buy	+16,800	New	+$881K	0.04%	117
2014 Q1	–	Sell	-13,400	Closed	-$708K	–	236
2013 Q4	$708K	Buy	13,400 +1,900	+17%	+$93.4K	0.03%	115
2013 Q3	$515K	Buy	+11,500	New	+$510K	0.03%	138

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Intact Investment Management's ABBV Position: Q1 2026 in Review

Intact Investment Management increased its AbbVie (ABBV) stake by 23% in Q1 2026, buying an estimated $4.4M and bringing the position to 107,630 shares worth $23.4M. The position accounts for 0.67% of the portfolio, ranked #37.

Intact Investment Management first reported a position in ABBV in Q3 2013 and has held it in 45 quarters since. The position peaked at $24.4M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Intact Investment Management held 107,630 shares of AbbVie worth $23.4M as of Q1 2026.
Intact Investment Management bought 19,840 AbbVie shares in Q1 2026, an estimated $4.4M.
AbbVie made up 0.67% of Intact Investment Management's portfolio in Q1 2026, its #37 holding.
Intact Investment Management first reported a position in AbbVie in Q3 2013 and has held it in 45 quarters since.
Intact Investment Management's AbbVie position peaked at $24.4M in Q3 2025.
4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Intact Investment Management's 13F filing for Q1 2026, filed 8 May 2026.